* BioLife Solutions Inc BLFS.OQ reported a quarterly
adjusted
loss of 50 cents per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -23 cents. The mean expectation of eight analysts for
the quarter was for a loss of 14 cents per share. Wall Street
expected results to range from -21 cents to -9 cents per share.
* Revenue fell 28.3% to $28.33 million from a year ago;
analysts
expected $23.95 million.
* BioLife Solutions Inc's reported EPS for the quarter was a
loss
of 50 cents.
* The company reported a quarterly loss of $7.15 million.
* BioLife Solutions Inc shares had risen by 2.9% this
quarter and
gained 35.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 23.3%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for BioLife Solutions
Inc is $26.00
This summary was machine generated from LSEG data August 8 at
10:05 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.14 -0.50 Missed
Mar. 31 2024 -0.28 -0.23 Beat
Dec. 31 2023 -0.34 -0.30 Beat
Sep. 30 2023 -0.37 -0.30 Beat